scholarly journals The role of antioxidant therapy in the treatment of male infertility: an overview

2011 ◽  
Vol 13 (5) ◽  
pp. 690-697 ◽  
Author(s):  
Francesco Lombardo ◽  
Andrea Sansone ◽  
Francesco Romanelli ◽  
Donatella Paoli ◽  
Loredana Gandini ◽  
...  
2010 ◽  
Vol 13 (4) ◽  
pp. 217-225 ◽  
Author(s):  
Ashok Agarwal ◽  
Lucky H. Sekhon

Author(s):  
Nikolaos Sofikitis ◽  
Aris Kaltsas ◽  
Fotios Dimitriadis ◽  
Jens Rassweiler ◽  
Nikolaos Grivas ◽  
...  

The therapeutic range of cyclic nucleotide phosphodiesterase 5 inhibitors (PDE5) inhibitors is getting wider in the last years. This review study focuses on the potential employment of PDE5 inhibitors as an adjunct tool for the therapeutic management of male infertility. The literature tends to suggest a beneficial effect of PDE5 inhibitors on Leydig and Sertoli cells secretory function. It also appears that PDE5 inhibitors play a role in the regulation of the contractility of the testicular tunica albuginea and the epididymis. Moreover scientific data suggest that PDE5 inhibitors enhance the prostatic secretory function leading to an improvement in sperm motility. Other studies additionally demonstrate a role of PDE5 inhibitors in the regulation of sperm capacitation process. Placebo-controlled, randomized, blind studies are necessary to unambiguously incorporate PDE5 inhibitors as an adjunct tool for the pharmaceutical treatment of semen disorders and male infertility.


Author(s):  
Khavkina D.A. Khavkina ◽  
Ruzhentsova Т.А. Ruzhentsova ◽  
Chukhlyaev P.V. Chukhlyaev ◽  
Garbuzov А.А. Garbuzov ◽  
Shushakova E.K. Shushakova ◽  
...  

Author(s):  
Khavkina D.A. Khavkina ◽  
Ruzhentsova Т.А. Ruzhentsova ◽  
Chukhlyaev P.V. Chukhlyaev ◽  
Garbuzov А.А. Garbuzov ◽  
Shushakova E.K. Shushakova ◽  
...  

2014 ◽  
Vol 86 (3) ◽  
pp. 164 ◽  
Author(s):  
Davide Arcaniolo ◽  
Vincenzo Favilla ◽  
Daniele Tiscione ◽  
Francesca Pisano ◽  
Giorgio Bozzini ◽  
...  

Objective: Infertility affects 15% of couples in fertile age. Male factor is a cause of infertility in almost half of cases, mainly due to oligoasthenoteratozoospermia (OAT). The purpose of this study is to review the effects of nutritional supplements as medical treatment for idiopathic male infertility. Material and methods: A Pub Med and Medline review of the published studies utilizing nutritional supplements for the treatment of male infertility has been performed. Results: Clinical trials on Vitamin E, Vitamin A, Vitamin C. Arginine, Carnitine, N-Acetyl-Carnitine, Glutathione, Coenzyme Q10, Selenium and Zinc were reviewed. Although there is a wide variability in selected population, dose regimen and final outcomes, nutritional supplements both alone and in combination seems to be able to improve semen parameters (sperm count, sperm motility and morphology) and pregnancy rate in infertile men. Conclusions: There are rising evidences from published randomized trials and systematic review suggesting that nutritional supplementation may improve semen parameters and the likelihood of pregnancy in men affected by OAT. This improvement, however, is not consistent and there is a wide variation in the treatment regimens used. Well designed and adequately powered RCTs are needed to better clarify the role of nutritional supplements as treatment for male infertility.


Sign in / Sign up

Export Citation Format

Share Document